Camilla Hammerum is VP and Therapeutic Area Lead for Neuroscience in Global Patient Safety (GPS) at Ipsen based in the UK. For 3½ years, she has led the Neuroscience Team within GPS, to ensure effective, proactive medical safety strategies and continuous management of the safety profile for all development compounds and marketed products within the TA, so that safety considerations reliably inform project decision-making.
Prior to joining Ipsen, Camilla worked for almost 10 years at Lundbeck. In her last post as Head of Medical Safety, Psychiatry in Global Pharmacovigilance. Camilla is a member of the Faculty of Pharmaceutical Medicine in London and before joining the industry, she practised as a GP.